Related Experiment Videos
Cancer genetics: tumor suppressor meets oncogene
1Division of Molecular Medicine and Genetics, Department of Internal Medicine, Human Genetics, University of Michigan Cancer Center, Ann Arbor, 48109-0638 USA. fearon@umich.edu
Current Biology : CB
|February 18, 1999
Summary
Mutations in the adenomatous polyposis coli (APC) protein are common in colorectal cancer. Alterations in APC signaling can lead to increased c-MYC gene activity, a key factor in cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The adenomatous polyposis coli (APC) protein is a critical tumor suppressor.
- APC mutations are prevalent in the majority of colorectal cancers.
- The c-MYC gene is a known oncogene implicated in cancer progression.
Purpose of the Study:
- To investigate the relationship between APC signaling pathway alterations and c-MYC transcriptional activation.
- To understand the molecular mechanisms linking APC inactivation to oncogene expression in colorectal cancer.
Main Methods:
- Analysis of gene expression data from colorectal cancer samples.
- Investigation of signaling pathways involving APC and c-MYC.
- Molecular biology techniques to assess transcriptional activation.
Main Results:
- A significant correlation was observed between alterations in the APC signaling pathway and the transcriptional activation of the c-MYC gene.
- Evidence suggests that disrupted APC function directly influences c-MYC expression levels.
Conclusions:
- Inactivation of the APC tumor suppressor is linked to the upregulation of the c-MYC oncogene in colorectal cancer.
- Targeting the APC-c-MYC axis may offer new therapeutic strategies for colorectal cancer treatment.